SGLTi
Showing 1 - 5 of 5
Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)
Not yet recruiting
- Nephropathy
- +6 more
- Sotagliflozin
- Placebo
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Nov 19, 2023
Type2 Diabetes, Heart Failure With Reduced Ejection Fraction Trial in Hong Kong (Dapagliflozin)
Active, not recruiting
- Type2 Diabetes
- Heart Failure With Reduced Ejection Fraction
-
Hong Kong, Hong KongQueen Mary Hospital
Aug 2, 2021
Heart Failure, Diastolic, Diabetes, Type 2 Trial in Cleveland (Ertugliflozin 5 mg, Placebo oral tablet)
Recruiting
- Heart Failure, Diastolic
- Diabetes Mellitus, Type 2
- Ertugliflozin 5 mg
- Placebo oral tablet
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Dec 10, 2021
Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)
Not yet recruiting
- Heart Failure With Preserved Ejection Fraction
- Diabete Type 2
-
Cairo, Egyptclinical research uint- El-sheikh zayed specialized hospital SMC
Oct 8, 2023